{"transactions":[{"id":724984,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:14:25.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":375000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001429933-26-000002","document":"form4-06292026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000142993326000002/form4-06292026_080621.xml","form_type":"4"}},{"id":1119010,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:13:34.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":300000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-25-016227","document":"form4-06092025_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016227/form4-06092025_080629.xml","form_type":"4"}},{"id":1370401,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2024-11-12T13:01:10.000Z","date":"2024-11-11","kind":"purchase","planned":false,"acquired":true,"shares":11500,"price":26.82,"value":308430.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,092 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":40284,"source":{"system":"sec-edgar","filing":"0001415889-24-026489","document":"form4-11122024_011107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924026489/form4-11122024_011107.xml","form_type":"4"}},{"id":1478176,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:12:26.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":300000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-24-017159","document":"form4-06172024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017159/form4-06172024_080622.xml","form_type":"4"}},{"id":1850846,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-06-20T20:13:13.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":250000,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001415889-23-010039","document":"form4-06202023_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010039/form4-06202023_080657.xml","form_type":"4"}},{"id":2183185,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option","published_at":"2022-08-17T20:06:50.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of June 13, 2022, the option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019."}],"balance_after":26665,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-22-008769","document":"form4-08172022_010842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008769/form4-08172022_010842.xml","form_type":"4"}},{"id":2183184,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option","published_at":"2022-08-17T20:06:50.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":25000,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-22-008769","document":"form4-08172022_010842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008769/form4-08172022_010842.xml","form_type":"4"}},{"id":2183183,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2022-08-17T20:06:50.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":120000,"price":37.6631,"value":4519572.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.39 to $37.95 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":27692,"source":{"system":"sec-edgar","filing":"0001415889-22-008769","document":"form4-08172022_010842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008769/form4-08172022_010842.xml","form_type":"4"}},{"id":2183182,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2022-08-17T20:06:50.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":45000,"price":9.0165,"value":405742.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 1,075,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the reverse stock split that occurred on February 8, 2019."}],"balance_after":147692,"source":{"system":"sec-edgar","filing":"0001415889-22-008769","document":"form4-08172022_010842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008769/form4-08172022_010842.xml","form_type":"4"}},{"id":2183181,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2022-08-17T20:06:50.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":75000,"price":2.78,"value":208500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 461 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":102692,"source":{"system":"sec-edgar","filing":"0001415889-22-008769","document":"form4-08172022_010842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008769/form4-08172022_010842.xml","form_type":"4"}},{"id":2229176,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-06-17T20:10:02.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":250000,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001415889-22-006709","document":"form4-06172022_010652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006709/form4-06172022_010652.xml","form_type":"4"}},{"id":2610978,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option","published_at":"2021-08-09T11:21:16.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 180,400 shares at an exercise price of $2.80 per share, but has been adjusted to reflect the Reverse Stock Split. The remaining 8,488 shares of common stock underlying the option expired on August 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of August 5, 2015, the option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This option was previously reported as covering 180,400 shares at an exercise price of $2.80 per share, but has been adjusted to reflect the Reverse Stock Split. The remaining 8,488 shares of common stock underlying the option expired on August 5, 2021."}],"balance_after":0,"derivative":{"exercise_price":42,"expiration_date":"2021-08-05","underlying":"Common Stock","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001179110-21-008010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021008010/edgar.xml","form_type":"4"}},{"id":2610977,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-09T11:21:16.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":3537,"price":42,"value":148554.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 180,400 shares at an exercise price of $2.80 per share, but has been adjusted to reflect the Reverse Stock Split. The remaining 8,488 shares of common stock underlying the option expired on August 5, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,256 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Option Plan.  On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":27231,"source":{"system":"sec-edgar","filing":"0001179110-21-008010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021008010/edgar.xml","form_type":"4"}},{"id":2662446,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-21T20:26:23.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":224000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":224000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":224000},"source":{"system":"sec-edgar","filing":"0001179110-21-006903","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006903/edgar.xml","form_type":"4"}},{"id":3104880,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-06-19T12:04:55.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":245000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001179110-20-007590","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007590/edgar.xml","form_type":"4"}},{"id":3115612,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-06-10T11:54:02.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":15000,"price":3.06,"value":45900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,103 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan."}],"balance_after":19438,"source":{"system":"sec-edgar","filing":"0001179110-20-007163","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/edgar.xml","form_type":"4"}},{"id":3483573,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-06-20T20:27:30.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":100000,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-19-007972","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007972/edgar.xml","form_type":"4"}},{"id":3893268,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-06-15T11:38:54.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":1075000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":1075000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":1075000},"source":{"system":"sec-edgar","filing":"0001179110-18-008563","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008563/edgar.xml","form_type":"4"}},{"id":4280091,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35026,"kind":"person","name":"Marucci Anthony S","position":1,"cik":"0001429933","reported_name":"Marucci Anthony S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-06-16T13:26:38.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts)over the subsequent 12 quarters."}],"balance_after":475000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001179110-17-009153","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009153/edgar.xml","form_type":"4"}}]}